Reverse-Transcriptase Inhibitors in the Aicardi–Goutières Syndrome

N Engl J Med. 2018 Dec 6;379(23):2275-7. doi: 10.1056/NEJMc1810983.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autoimmune Diseases of the Nervous System / drug therapy*
  • Autoimmune Diseases of the Nervous System / metabolism
  • Cerebrovascular Circulation / drug effects
  • Dideoxynucleosides / therapeutic use
  • Drug Combinations
  • France
  • Gene Expression / drug effects
  • Humans
  • Interferons / genetics
  • Interferons / metabolism*
  • Lamivudine / therapeutic use
  • Nervous System Malformations / drug therapy*
  • Nervous System Malformations / metabolism
  • Pilot Projects
  • Reverse Transcriptase Inhibitors / therapeutic use*
  • Zidovudine / therapeutic use

Substances

  • Dideoxynucleosides
  • Drug Combinations
  • Reverse Transcriptase Inhibitors
  • abacavir, lamivudine drug combination
  • Lamivudine
  • Zidovudine
  • Interferons

Supplementary concepts

  • Aicardi-Goutieres syndrome